What is NDC 68462-409?

68462-409 is the product NDC for propafenone hydrochloride, Propafenone hydrochloride 325 mg/1 capsule, extended release, listed with the FDA by Glenmark Pharmaceuticals Inc., USA. It has 1 package NDC, shown above in 10- and 11-digit form.

Glenmark Pharmaceuticals Inc., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for propafenone hydrochloride?

52 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

propafenone hydrochloride NDC 68462-409

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-409Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0409Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68462-409-60	6846204096068462040960	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-409-60)Marketed from Sep 8, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): propafenone hydrochloride
Generic name (nonproprietary): propafenone hydrochloride
Active ingredients: Propafenone hydrochloride — 325 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Glenmark Pharmaceuticals Inc., USANDC labeler code 68462
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205268
Marketing start: Sep 8, 2017
Listing expires: Dec 31, 2027
Identifiers: Product ID 68462-409_9b3e09a2-c396-425e-a1dc-e37cd44b612dSPL ID 9b3e09a2-c396-425e-a1dc-e37cd44b612dSPL set ID d818af31-2535-4595-82fe-fd7abf66fd6cRxCUI 861156, 861164, 861171UNII 33XCH0HOCDUPC 0368462409602, 0368462410608, 0368462408605
Pharmacologic class: Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462040960 followed by a unit qualifier and the quantity

Package 68462-0409-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Propafenone hydrochloride extended-release capsules are indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease. Usage Considerations: • The use of propafenone hydrochloride extended-release capsules in patients with permanent AF or in patients exclusively with atrial flutter or paroxysmal supraventricular tachycardia (PSVT) has not been evaluated. Do not use propafenone hydrochloride extended-release capsules to control ventricular rate during AF. • Some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an incre…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68462-409

What is NDC 68462-409?: 68462-409 is the product NDC for propafenone hydrochloride, Propafenone hydrochloride 325 mg/1 capsule, extended release, listed with the FDA by Glenmark Pharmaceuticals Inc., USA. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: propafenone hydrochloride.
What is the active ingredient?: Propafenone hydrochloride.
Who is the labeler?: Glenmark Pharmaceuticals Inc., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for propafenone hydrochloride?: 52 other product NDCs are listed under this name. See all propafenone hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other propafenone hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Propafenone Hydrochloride	Propafenone hydrochloride 150 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-930	60687-0930-01
Propafenone Hydrochloride	Propafenone hydrochloride 300 mg/1	Tablet, Film coatedOral	Strides Pharma Science Limited	64380-246	64380-0246-01
Propafenone Hydrochloride	Propafenone hydrochloride 225 mg/1	Tablet, Film coatedOral	Strides Pharma Science Limited	64380-268	64380-0268-0164380-0268-02
Propafenone Hydrochloride	Propafenone hydrochloride 150 mg/1	Tablet, Film coatedOral	Strides Pharma Science Limited	64380-269	64380-0269-0164380-0269-02
Propafenone Hydrochloride	Propafenone hydrochloride 225 mg/1	Capsule, Extended releaseOral	Aurobindo Pharma Limited	59651-276	59651-0276-0559651-0276-6059651-0276-90
Propafenone Hydrochloride	Propafenone hydrochloride 325 mg/1	Capsule, Extended releaseOral	Aurobindo Pharma Limited	59651-277	59651-0277-0559651-0277-6059651-0277-90
Propafenone Hydrochloride	Propafenone hydrochloride 425 mg/1	Capsule, Extended releaseOral	Aurobindo Pharma Limited	59651-278	59651-0278-0559651-0278-6059651-0278-90
Propafenone Hydrochloride	Propafenone hydrochloride 150 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-709	60687-0709-01
Propafenone Hydrochloride	Propafenone hydrochloride 300 mg/1	Tablet, Film coatedOral	Strides Pharma Science Limited	64380-163	64380-0163-01
Propafenone Hydrochloride	Propafenone hydrochloride 225 mg/1	Tablet, Film coatedOral	Strides Pharma Science Limited	64380-164	64380-0164-0164380-0164-02

All 53 propafenone hydrochloride NDCs

Other NDCs under ANDA 205268

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205268
Product	Strength	Form · route	Labeler	Product NDC
propafenone hydrochloride	Propafenone hydrochloride 225 mg/1	Capsule, Extended releaseOral	Northstar Rx LLC	16714-825
propafenone hydrochloride	Propafenone hydrochloride 325 mg/1	Capsule, Extended releaseOral	Northstar Rx LLC	16714-826
propafenone hydrochloride	Propafenone hydrochloride 425 mg/1	Capsule, Extended releaseOral	Northstar Rx LLC	16714-827
propafenone hydrochloride	Propafenone hydrochloride 225 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-408
propafenone hydrochloride	Propafenone hydrochloride 425 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-410